Discover 1,444 paid clinical trials in Akron, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,444
Maintaining Lower Levels of Care Through Automated Perineal Hygiene
for
Incontinence, Dermatitis
Location: Garfield Heights OH, Rancho Palos Verdes CA
Sponsor: SchwabCare
Sex: All
Age: 18+
Code: NCT03051321
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Canton OH, Cleveland OH, Westlake OH, Pittsburgh PA,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07184931
Phase 3, Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis
Location: Canton OH, Westlake OH, Pittsburgh PA, Columbus OH,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07184996
Phase 3, Recruiting
A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer
for
Advanced Solid Tumors, Non-Small Cell Lung Cancer
Location: Ohio City OH
Sponsor: Chong Kun Dang Pharmaceutical
Sex: All
Age: 19+
Code: NCT07439094
Phase 1, Phase 2, Recruiting
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
for
Solid Malignancies, Hematologic Malignancies
Location: Canton OH, Ann Arbor MI, Grand Rapids MI,
Sponsor: Immunome, Inc.
Sex: All
Age: 18+
Code: NCT06823167
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Location: Breckville OH, Indianapolis IN, Lake Villa, IL,
Sponsor: Innovative Medical
Sex: All
Age: 18+
Code: NCT01278420
Recruiting
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
for
Chronic Myelogenous Leukemia - Chronic Phase
Location: Canton OH, Baltimore MD, Syracuse NY, Decatur IL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07091019
Recruiting
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
A Study to Assess the Safety, Tolerability and Efficacy of ION775
for
Hypertriglyceridemia, Severe Hypertriglyceridemia
Location: Munroe Falls OH, Flint MI, Carmel IN, Little River SC,
Sponsor: Ionis Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07604974
Phase 2, Recruiting
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Silver Nitrate Application and Topical Corticosteroids for Hypergranulation Tissue
for
Hypergranulation Tissue; Gastrostomy Tube Site
Location: Akron OH
Sponsor: Akron Children's Hospital
Sex: All
Age: 0 - 18
Code: NCT02398539
Recruiting
Active & Responsive
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder (GAD)
Location: Avon Lake OH, Columbus OH, Cincinnati OH,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT06846320
Phase 2, Recruiting
Active & Responsive
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
for
Major Depressive Disorder
Location: Avon Lake OH, Columbus OH, Chicago IL, Warrenville IL,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07276997
Phase 2, Recruiting
Active & Responsive
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Mansfield OH, Marion OH, Delaware OH, Westerville OH,
Sponsor: Eastern Cooperative Oncology Group
Sex: All
Age: 18 - 70+
Code: NCT06724237
Phase 3, Recruiting
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Farrell PA, Wexford PA, Pittsburgh PA, Washington PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07195734
Phase 2, Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
for
Non-Muscle Invasive Bladder Urothelial Carcinoma,
Location: Farrell PA, Mansfield OH, New Castle PA, Pittsburgh PA,